| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | Finland | 1 | |
| #7 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Measurement | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Pharmaceuticals | |
| #5 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Peptides | |
| #3 | Diagnosis and surgery | |
| #4 | Medical preparations | |
| #5 | Acyclic or carbocyclic compounds | |
| #6 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Harel Adrian | 15 |
| #2 | Valimaa Lasse | 5 |
| #3 | Adrian Harel | 1 |
| #4 | Välimaa Lasse | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021038125A2 | Conjugates and conjugates for use in preventing or treating of brain damage and neurodegenerative diseases | |
| AU2018223316A1 | Non-invasive brain injury diagnostic device | |
| EP3283880A1 | Prognostic and diagnostic glycan-based biomarkers of brain damage | |
| EP3201173A1 | Multivalent compounds for use in the treatment and prevention of brain damage |